Clinical Trial Update: Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain [Phase 2]

View source ↗

Summary

Phase 2 study evaluating mesenchymal precursor cells (MPCs) for safety and preliminary efficacy in subjects with degenerative disc disease; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• Mesenchymal precursor cells (MPCs)

Snippet

Sponsor: Mesoblast, Ltd. | Conditions: Degenerative Disc Disease | Phase 2 | Status: COMPLETED